Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.3 USD | -0.61% | -1.94% | -2.95% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.95% | 2.48B | |
-1.44% | 41.35B | |
+42.27% | 40.38B | |
+3.34% | 39.05B | |
-12.11% | 26.67B | |
+2.58% | 24.07B | |
-23.96% | 18.36B | |
-3.90% | 11.68B | |
+22.88% | 11.6B | |
+7.65% | 11.15B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Guggenheim Adjusts Price Target on Celldex Therapeutics to $63 From $68, Maintains Buy Rating